Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 317-325

  Perez Mendez, Oscar ^a   Bruckert, Eric ^b   Franceschini, Guido ^d   Duhal, Nathalie ^c   Lacroix, Brigitte ^c   Bonte, Jean Paul ^c   Sirtori, Cesare ^d   Fruchart, Jean Charles ^a   Turpin, Gérard ^a   Luc, Gérald ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIV LILLE   (France)

^d Istituto di Scienze Farmacologiche   (Italy)

Author keywords

Apolipoprotein AI; Hypoalphalipoproteinemia; Kinetics; Stable isotope

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ARGININE; CYSTEINE; DEUTERIUM; DIMER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; MONOMER; MUTANT PROTEIN; STABLE ISOTOPE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CATABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; KINETICS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MUTATION; PRIORITY JOURNAL; SYNTHESIS;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; DIMERIZATION; HETEROZYGOTE; HUMANS; KINETICS; MALE; MIDDLE AGED; MUTATION;

EID: 0033977770     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00279-8     Document Type: Article

References (26)

1. Brewer H.B. Jr, Gregg R.E., Hoeg J.M., Fojo S.S. Apolipoproteins and lipoproteins in human plasma: an overview. Clin. Chem. 34:1988;B4-B8.
2. Assmann G., Schmitz G., Brewer H.B. The Metabolic Basis of Inherited Disease. 1989;1267-1282 McGraw-Hilll, New York.
3. Breslow J.L. Familial Disorders of High Density Lipoprotein Metabolism. 6th edn:1989;1251-1266 McGraw-Hill, New York.
4. De Backer G., Rosseneu M., Deslypere J.P. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis. 42:1982;197-203.
5. Gordon T., Castelli W.P., Hjortland M.C., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62:1977;707-714.
6. Vergani C., Bettale G. Familial hypo-alpha-lipoproteinemia. Clin. Chim. Acta. 114:1981;45-52.
7. Rader D.J., Ikewaki K., Duverger N., Feuerstein I., Zech L., Connor W., Brewer H.B. Jr Very low high-density lipoproteins without coronary atherosclerosis. Lancet. 342:1993;1455-1458.
8. Weisgraber K.H., Rall S.C. Jr, Bersot T.P., Mahley R.W., Franceschini G., Sirtori C.R. Apolipoprotein AIMilano. Detection of normal AI in affected subjects and evidence for a cysteine for arginine substitution in the variant AI. J. Biol. Chem. 258:1983;2508-2513.
9. Bruckert E., Voneckardstein A., Funke H., Beucler I., Wiebusch H., Turpin G., Assmann G. The replacement of arginine by cysteine at residue 151 in apolipoprotein AI produces a phenotype similar to that of apolipoprotein AI-Milano. Atherosclerosis. 128:1997;121-128.
10. Weisgraber K.H., Bersot T.P., Mahley R.W., Franceschini G., Sirtori C.R. AImilano apoprotein. Isolation and characterization of a cysteine-containing variant of the AI apoprotein from human high density lipoproteins. J. Clin. Invest. 66:1980;901-907.
11. Roma P., Gregg R.E., Meng M.S., Ronan R., Zech L.A., Franceschini G. et al. In vivo metabolism of a mutant form of apolipoprotein AI, apoAIMilano, associated with familial hypoalphalipoproteinemia. J. Clin. Invest. 91:1993;1445-1452.
12. Franceschini G., Sirtori C.R., Cadurso A., Weisgraber K.H., Mahley R.W. AI Milano apoprotein: decreased high density lipoprotein levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J. Clin. Invest. 66:1980;892-900.
13. Franceschini G., Sirtori C.R., Bosisio E., Gualandri V., Orsini G.B., Mogavero A.M., Capurso A. Relationship of the phenotypic expression of the AIMilano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis. 58:1985;159-174.
14. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
16. Higgins R.C., Dahmus M.E. Rapid visualisation of bands in preparative SDS-polyacrylamide gels. Anal. Biochem. 93:1979;257-260.
17. Cobelli C., Toffolo G., Foster D.M. Tracer to tracee ratio for analysis of stable tracer data: link with radioactive kinetic formalism. Am. J. Physiol. 262:1992;E968-E975.
18. Reeds P.J., Hachey D.L., Patterson B.W., Motil K.J., Klein P.D. VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids. J. Nutr. 122:1992;457-466.
19. Parra H.J., Mezdour H., Ghalim N., Bard J.M., Fruchart J.C. Differential electroimmunoassay of human LpAI lipoprotein particles on ready-to-use plates. Clin. Chem. 36:1990;1431-1435.
20. Menzel H.J., Utermann G. Apolipoprotein E phenotyping from serum Western blotting. Electrophoresis. 12:1988;120-125.
21. Fenner C., Traut R.R., Mason D.T., Wikman-Coffelt J. Quantification of Coomassie Blue stained proteins in polyacrylamide gels based on analyses of eluted dye. Anal. Biochem. 63:1975;595-602.
22. Parra H.J., Arveiler D., Evans A.E., Cambou J.P., Amouyel P., Gingham A. et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler. Thromb. 12:1992;701-707.
23. Cheung M.C., Nichols A.V., Blanche P.J., Gong E.L., Franceschini G., Sirtori C.R. Characterization of AI-containing lipoproteins in subjects with AI Milano variant. Biochim. Biophys. Acta. 960:1988;73-82.
24. Franceschini G., Calabresi L., Tosi C., Gianfranceschi G., Sirtori C.R., Nichols A.V. Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma. J. Biol. Chem. 265:1990;12224-12231.
25. Calabresi L., Vecchio G., Frigerio F., Vavassori L., Sirtori C.R., Franceschini G. Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein AI dimer: Evidence for restricted particle size heterogeneity. Biochemistry. 36:1997;12428-12433.
26. Calabresi L., Franceschini G., Burkybile A., Jonas A. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein AI dimer. Biochem. Biophys. Res. Commun. 232:1997;345-349.